NASDAQ:JAZZ | Free Cash Flow | Jazz Pharmaceuticals plc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$408.2M$19.7M$388.5M132.55%
2025-12-31$362.52M$16.73M$345.79M169.96%
2025-03-31$429.8M$13.9M$415.9M
2024-12-31$398.58M$13.29M$385.29M201.60%
2024-03-31$267.23M$6.9M$260.33M
2023-12-31$167.34M$10.1M$157.24M167.00%
2023-03-31$320.71M$3.82M$316.89M456.48%
2022-12-31$341.97M$9.38M$332.59M
2022-03-31$208.98M$12.29M$196.69M11942.14%
2021-12-31$177.76M$9.97M$167.79M
2021-03-31$285M$2.17M$282.83M232.15%
2020-12-31$186.27M$4.12M$182.16M136.53%
2020-03-31$272.97M$4.83M$268.14M
2019-12-31$87.8M$7.14M$80.66M109.01%
2019-03-31$202.25M$7.95M$194.31M228.05%
2018-12-31$218.1M
2018-03-31$167.36M
2017-12-31$204.56M
2017-03-31$164.54M
2016-12-31$180.7M
2016-03-31$151.65M
2015-12-31$119.74M
2015-03-31$96.56M
2014-12-31$134.26M
2014-03-31$68.72M
2013-12-31$79.03M
2013-03-31$69.89M
2012-12-31$104.35M
2012-03-31$24.3M
2011-12-31$43.66M
2011-03-31$24.45M
2010-12-31$22.79M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$1.36B$58.75M$1.3B
2024-12-31$1.4B$38.07M$1.36B242.42%
2023-12-31$1.09B$23.96M$1.07B257.46%
2022-12-31$1.27B$29.05M$1.24B
2021-12-31$778.51M$27.64M$750.87M
2020-12-31$899.65M$15M$884.64M370.74%
2019-12-31$776.4M$40.14M$736.27M140.68%
2018-12-31$798.9M$20.37M$778.53M174.13%
2017-12-31$693.09M
2016-12-31$592.39M
2015-12-31$531.94M
2014-12-31$407.61M
2013-12-31$288.43M
2012-12-31$249.75M
2011-12-31$151.6M
2010-12-31$58.87M
2009-12-31-$15.88M